Altimmune ALT
NASDAQ ALT
$2.78 -0.08 (-2.97%)
As of: Oct 1, 2026 · 12:51 PM EDT

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019)

Updated

Altimmune's Long-Term Debt Repayments came in at $632,000 for FY2020, up 116.4% from $292,002 in FY2019.

Analysis

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019) Analysis & Trends

Going back to FY2010, Altimmune's Long-Term Debt Repayments data covers 6 years.

  • Long-Term Debt Repayments carries a four-year compound annual growth rate of 67.1% (FY2016 to FY2020).
  • The five-year range for annual Long-Term Debt Repayments is $81,098 (FY2016) to $1.55 million (FY2018).
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $292,002 in FY2019 (-81.2%), $1.55 million in FY2018 (+629.5%), $212,431 in FY2017 (+161.9%) and $81,098 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Altimmune 556.20 Mn 556.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 105,062.00
Sep 30, 2019 30,795.00
Dec 31, 2016 80,999.00
API Access

Altimmune Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ALT&period=max&api_key=YOUR_API_KEY